Pnömoniler

Heron, M. P. (2017). Deaths: leading causes for 2015.

Plouffe, J. F., & Martin, D. R. (2008). Pneumonia in the emergency department. Emergency medicine clinics of North America, 26(2), 389-411.

Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., ... & Griffin, M. R. (2019). Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American journal of respiratory and critical care medicine, 200(7), e45-e67.

Türkiye İstatistik Kurumu, Sağlık İstatistikleri (http://www.tuik.gov.tr)

Alves DW, Kennedy MT. Community-acquired pneumonia in casualty: Etiology, clinical features, diagnosis, and management (or a look at the “new” in pneumonia since 2002). Curr Opin Pulm Med 2004; 10: 166-70

Bates JH, Campbell GD, Barron AL, et al. Microbial etiology of acute pneumonia in hospitalized patients. Chest 1992; 101: 1005-12.

File TM, Garau J, Blasi F, et al. Guidlines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest 2004;125:1888-901.

Özlü T, Bülbül Y, Ozsu S. [Community-acquired pneumonia based on the Turkish national data]. Tuberk Toraks 2007;55(2):191-212. PMid:17602349

Sever F, Kömüs N, Esen N, Gündüz AT, Öktem MA, Çımrın AH. Türkiye’de Toplum Kökenli Pnömoni Etyoloji ve Epidemiyolojisi. Turk Toraks Derg 2013; 14: 5-10.

Köksal I, Ozlü T, Bayraktar O, Yılmaz G, Bülbül Y, Oztuna F, et al. Etiological agents of community-acquired pneumonia in adult patients in Turkey; a multicentric, cross-sectional study. Tuberk Toraks 2010; 58: 119-27

Alcón, A., Fàbregas, N., & Torres, A. (2005). Pathophysiology of pneumonia. Clinics in chest medicine, 26(1), 39-46.

Özlü T, Bülbül Y, Alataş F, Arseven O, Şakar Coşkun A ve ark. Türk Toraks Derneği Erişkinlerde Toplumda Gelişen Pnömoni Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Dergisi 2009; 10: Ek 9

File Jr, T. M. (2003). Community-acquired pneumonia. The Lancet, 362(9400), 1991-2001.

M File T, Bartlett JG, Thorner AR. Treatment of community-acquired pneumonia in adults in the outpatient setting.Literature review current through:UpToDate May 2016. at www.uptodate. Com

15-Işık S. Akciğer infeksiyonları radyolojisi. In: Numanoğlu N, Willke A, ed. Güncel Bilgiler Işığında Pnömoniler. Ankara: Bilimsel Tıp Yayınevi, 2000:129-72

Upadhyay S, Niederman MS. Biomarkers: what is their benefit in the identification of infection, severity assessment, and management of community-acquired pneumonia? Infect Dis Clin North Am 2013;27:19-31.

Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-44.

Lim, W. S., Baudouin, S. V., George, R. C., Hill, A. T., Jamieson, C., Le Jeune, I., ... & Wani, M. (2009). BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax, 64(Suppl 3), iii1-iii55.

Erdem H, Kiliç S, Pahsa A, Besirbellioglu. Gram-negative bacterial resistance to cephalosporins in communityacquired infections in Turkey. J Chemother 2005;17:61-5.

Arancibia F, Bauer TT, Ewig S, Mensa J, Gonzalez J, Niederman MS,et al. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med 2002;162:1849–1858.

Grohskopf LA, Sokolow LZ, Olsen SJ, et al. Prevention and control of influenza with vaccines: Recommendations of the Advisory Comittee on Immunization Practices, United States, 2015-16 influenza season. MMWR. August 7, 2015;64:818-25

Daoud E, Guzman J. Are antibiotics indicated for the treatment of aspiration pneumonia? Cleveland Clinic Journal of Medicine 2010;77:573-576

Sym D, Patel PM, El-Chaar GM. Seasonal, avain and novel H1N1 influenza: prevention and treatment modalities. Ann Pharmacother 2009;43:2001–11.